---
pmid: '24658140'
title: The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein
  interactions in human cells.
authors:
- Petschnigg J
- Groisman B
- Kotlyar M
- Taipale M
- Zheng Y
- Kurat CF
- Sayad A
- Sierra JR
- Mattiazzi Usaj M
- Snider J
- Nachman A
- Krykbaeva I
- Tsao MS
- Moffat J
- Pawson T
- Lindquist S
- Jurisica I
- Stagljar I
journal: Nat Methods
year: '2014'
full_text_available: false
doi: 10.1038/nmeth.2895
---

# The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.
**Authors:** Petschnigg J, Groisman B, Kotlyar M, Taipale M, Zheng Y, Kurat CF, Sayad A, Sierra JR, Mattiazzi Usaj M, Snider J, Nachman A, Krykbaeva I, Tsao MS, Moffat J, Pawson T, Lindquist S, Jurisica I, Stagljar I
**Journal:** Nat Methods (2014)
**DOI:** [10.1038/nmeth.2895](https://doi.org/10.1038/nmeth.2895)

## Abstract

1. Nat Methods. 2014 May;11(5):585-92. doi: 10.1038/nmeth.2895. Epub 2014 Mar 23.

The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein 
interactions in human cells.

Petschnigg J(1), Groisman B(1), Kotlyar M(2), Taipale M(3), Zheng Y(4), Kurat 
CF(5), Sayad A(1), Sierra JR(2), Mattiazzi Usaj M(1), Snider J(1), Nachman A(1), 
Krykbaeva I(3), Tsao MS(6), Moffat J(7), Pawson T(8), Lindquist S(9), Jurisica 
I(10), Stagljar I(11).

Author information:
(1)Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
(2)Princess Margaret Cancer Centre, University Health Network, University of 
Toronto, Toronto, Ontario, Canada.
(3)Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
(4)Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, 
Canada.
(5)1] Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. [2].
(6)1] Princess Margaret Cancer Centre, University Health Network, University of 
Toronto, Toronto, Ontario, Canada. [2] Department of Medical Biophysics, 
University of Toronto, Toronto, Ontario, Canada. [3] Department of Laboratory 
Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
(7)1] Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. [2] 
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, 
Canada.
(8)1] Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, 
Ontario, Canada. [2].
(9)1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, 
USA. [2] Howard Hughes Medical Institute, Cambridge, Massachusetts, USA. [3] 
Department of Biology, Massachusetts Institute of Technology, Cambridge, 
Massachusetts, USA.
(10)1] Princess Margaret Cancer Centre, University Health Network, University of 
Toronto, Toronto, Ontario, Canada. [2] Department of Medical Biophysics, 
University of Toronto, Toronto, Ontario, Canada. [3] Department of Computer 
Science, University of Toronto, Toronto, Ontario, Canada.
(11)1] Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. [2] 
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, 
Canada. [3] Department of Biochemistry, University of Toronto, Toronto, Ontario, 
Canada.

Cell signaling, one of key processes in both normal cellular function and 
disease, is coordinated by numerous interactions between membrane proteins that 
change in response to stimuli. We present a split ubiquitin-based method for 
detection of integral membrane protein-protein interactions (PPIs) in human 
cells, termed mammalian-membrane two-hybrid assay (MaMTH). We show that this 
technology detects stimulus (hormone or agonist)-dependent and 
phosphorylation-dependent PPIs. MaMTH can detect changes in PPIs conferred by 
mutations such as those in oncogenic ErbB receptor variants or by treatment with 
drugs such as the tyrosine kinase inhibitor erlotinib. Using MaMTH as a 
screening assay, we identified CRKII as an interactor of oncogenic EGFR(L858R) 
and showed that CRKII promotes persistent activation of aberrant signaling in 
non-small cell lung cancer cells. MaMTH is a powerful tool for investigating the 
dynamic interactomes of human integral membrane proteins.

DOI: 10.1038/nmeth.2895
PMID: 24658140 [Indexed for MEDLINE]
